Previous close | 2.5000 |
Open | 2.5000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 42.50 |
Expiry date | 2024-08-16 |
Day's range | 2.5000 - 2.5000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Besides Wall Street's top -and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures and a more stable supply chain.
ResMed (RMD) delivered earnings and revenue surprises of 10.94% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?